Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

CTGLF3 Activators

CTGLF3 Activators are specialized molecules that could increase the function of CTGLF3 by enhancing its active site availability, altering its conformation to a more active state, or by facilitating its interaction with substrates or other molecular partners. The molecules in this class would likely have a high specificity for CTGLF3, utilizing a variety of molecular architectures to achieve selective binding. The diversity in structure would be reflective of the complexity and specificity required to interact with the unique sites of CTGLF3, which might include allosteric sites or domains critical for its activity.

To conceive CTGLF3 Activators, a detailed understanding of the structure and function of the CTGLF3 protein would be essential. This would involve comprehensive research into the protein's role at the molecular and cellular levels, including its expression patterns, cellular localization, and its potential role in cellular processes. Once the biological role of CTGLF3 was established, the development of activators could proceed by using a combination of computational modeling to predict interaction sites and high-throughput screening to identify potential compounds. These compounds would then be synthesized and tested for their ability to bind to and activate CTGLF3. Techniques such as affinity chromatography, surface plasmon resonance (SPR), or fluorescence-based assays might be employed to investigate the interaction between CTGLF3 and potential activators. Moreover, structural studies using X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy could provide insights into the binding modes and the conformational changes of CTGLF3 upon activator binding. These studies would help in mapping the activator binding sites and gaining a deeper understanding of the molecular mechanisms by which these activators exert their effects on CTGLF3.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC) which can modulate transcription factors and potentially increase AGAP6 expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

It activates retinoic acid receptors that can bind to DNA response elements and may upregulate AGAP6 expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG can modulate epigenetic marks, potentially affecting AGAP6 gene expression.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

As a histone deacetylase inhibitor, it may increase histone acetylation leading to enhanced AGAP6 expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor could demethylate the AGAP6 gene promoter, activating its transcription.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Another histone deacetylase inhibitor that could increase AGAP6 expression by altering chromatin structure.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium can impact Wnt signaling and GSK-3β activity, possibly influencing AGAP6 expression.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

It inhibits cyclin-dependent kinases (CDKs) and might affect cell cycle-related gene expression, including AGAP6.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Sulforaphane affects transcription factors and epigenetic regulators, which may induce AGAP6 gene expression.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

The active metabolite can modulate gene expression through the vitamin D receptor, potentially affecting AGAP6.